Takeda Pharmaceutical Company Limited (4502.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.92T |
| Enterprise Value | 13.21T |
| P/E Ratio | 41.08 |
| PEG Ratio | 0.53 |
| Price/Sales Ratio | 1.76 |
| Price/Book Ratio | 1.01 |
| Enterprise/Revenue | 2.71 |
| Enterprise/EBITDA | 8.98 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 4.51T |
| Revenue/Share | 2,883.52 |
| Gross Profit | 2.3T |
| EBITDA | 1.34T |
| Net Income | 191.76B |
| Diluted EPS | 119.64 |
Balance Sheet
| Total Cash | 595.05B |
| Total Cash/Share | 380.82 |
| Total Debt | 4.88T |
| Total Debt/Equity | 0.63 |
| Current Ratio | 1.27 |
| Book Value Per Share | 4,975.63 |
Price History
| 52-Week Change | 16.97 |
| 52-Week High | 6,033 |
| 52-Week Low | 4,102 |
| Moving Average 50 Days | 5,183.44 |
| Moving Average 200 Days | 4,987.35 |
Statistics
| Average Volume | 4.26M |
| Shares Outstanding | 1.58B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 200 |
| Trailing Annual Dividend Yield | 3.99 |
| Payout Ratio | 1.63 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
